0001534120 2026-07-13 2026-07-13 0001534120 1 2026-07-13 2026-07-13 iso4217:USD pure shares S-3 S-3 EX-FILING FEES 0001534120 Avalo Therapeutics, Inc. N/A N/A S-3 Avalo Therapeutics, Inc. false Equity Common Stock, $0.001 par value per share true 128189 18.52 2374060.28 0.0001381 327.86 2374060.28 327.86 0.00 0.00 327.86 Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement also registers up to 128,189 number of shares of common stock, $0.001 par value per share (the "Common Stock"), of Avalo Therapeutics, Inc. (the "Registrant") which may become issuable by reason of any stock dividend, stock split or other similar transaction effected without the receipt of consideration that results in an increase in the number of the outstanding shares of the Registrant's Common Stock. The proposed maximum per security and aggregate offering prices are based on the estimates solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act, based on the average of the high and low prices of the common stock as reported on Nasdaq Capital Market on July 13, 2026 of $18.52 per share.